{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:10:54Z","timestamp":1791295854128,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Systemic antifungal treatments are empirically administered to the sickest critically ill patients, often without documented invasive fungal infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the impact of systemic antifungal treatment on 30-day survival of patients suspected to have invasive candidiasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All nonneutropenic, nontransplant recipients managed in five intensive care units intubated for at least 5 days, and free of invasive candidiasis, were included. To account for differences in patients\u2019 characteristics recorded daily before study end point, a causal model for longitudinal data was used to assess benefits from antifungal treatment. The composite primary end point was hospital mortality or occurrence of invasive candidiasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Among 1,491 patients, 100 (6.7%) received antifungal treatment for a suspected infection. Patients treated with antifungals were more severely ill than untreated patients. Within the 30-day follow-up period, 363 (24.3%) patients died, and 22 (1.5%) exhibited documented invasive candidiasis. After adjustment on baseline and time-dependent confounders (underlying illness, severity, invasive procedures, Candida colonization), and using a marginal structural model for longitudinal data, treatment was not associated with a decreased risk of mortality or of occurrence of invasive candidiasis (hazard ratio, 1.05; 95% confidence interval, 0.56\u20131.96; P\u2009=\u20090.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study failed to show outcome benefits for empirical systemic antifungal therapy in the sickest critically ill, nonneutropenic, nontransplanted patients. The post hoc power did not allow us to conclude to an absence of treatment effect especially for specific subgroups. Studies to refine indications for empirical treatment based on surrogate markers of invasive candidiasis are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201409-1701oc","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T18:47:10Z","timestamp":1426618030000},"page":"1139-1146","source":"Crossref","is-referenced-by-count":52,"title":["Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients"],"prefix":"10.1093","volume":"191","author":[{"given":"S\u00e9bastien","family":"Bailly","sequence":"first","affiliation":[{"name":"Grenoble 1 University, U823, La Tronche, France"},{"name":"UMR 1137, IAME Team 5, DeSCID Inserm\/Paris Diderot, Sorbonne Paris Cit\u00e9 University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Bouadma","sequence":"additional","affiliation":[{"name":"Medical and Infectious Diseases ICU, Paris Diderot University\/Bichat Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[{"name":"Medical ICU, Saint-Louis University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mait\u00e9 Garrouste","family":"Orgeas","sequence":"additional","affiliation":[{"name":"Medical Surgical ICU, Saint-Joseph Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Adrie","sequence":"additional","affiliation":[{"name":"Department of Physiology, Cochin University Hospital, APHP, Paris, France"},{"name":"Medical-Surgical ICU, Delafontaine Hospital, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[{"name":"Medical ICU, Gabriel-Montpied University Hospital, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[{"name":"Medical ICU and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Maubon","sequence":"additional","affiliation":[{"name":"Parasitology-Mycology, Grenoble University Hospital, La Tronche, France"},{"name":"TIMC-IMAG UMR 5525 Joseph Fourier University, La Tronche, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hamidfar-Roy","sequence":"additional","affiliation":[{"name":"Medical ICU and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Darmon","sequence":"additional","affiliation":[{"name":"Medical ICU, Saint-Etienne University Hospital, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Wolff","sequence":"additional","affiliation":[{"name":"Medical and Infectious Diseases ICU, Paris Diderot University\/Bichat Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Cornet","sequence":"additional","affiliation":[{"name":"Parasitology-Mycology, Grenoble University Hospital, La Tronche, France"},{"name":"TIMC-IMAG UMR 5525 Joseph Fourier University, La Tronche, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[{"name":"UMR 1137, IAME Team 5, DeSCID Inserm\/Paris Diderot, Sorbonne Paris Cit\u00e9 University, Paris, France"},{"name":"Medical and Infectious Diseases ICU, Paris Diderot University\/Bichat Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"2026032100194839000_bib1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","article-title":"Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study","volume":"38","author":"Tabah","year":"2012","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib2","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"2026032100194839000_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","article-title":"Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)","volume":"40","author":"Lortholary","year":"2014","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10096-008-0618-z","article-title":"Fungal colonization and\/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study","volume":"28","author":"Le\u00f3n","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026032100194839000_bib7","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","article-title":"Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study","volume":"37","author":"Le\u00f3n","year":"2009","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1086\/500318","article-title":"Excess risk of death from intensive care unit-acquired nosocomial bloodstream infections: a reappraisal","volume":"42","author":"Garrouste-Orgeas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes","volume":"67","author":"Grim","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2026032100194839000_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026032100194839000_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"2026032100194839000_bib14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","article-title":"Invasive candidiasis in the intensive care unit","volume":"34","author":"Ostrosky-Zeichner","year":"2006","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00134-008-1338-7","article-title":"Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis","volume":"35","author":"Guery","year":"2009","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","article-title":"\u03b2-Glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis","volume":"188","author":"Tissot","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100194839000_bib17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00134-014-3281-0","article-title":"What\u2019s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients","volume":"40","author":"Le\u00f3n","year":"2014","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.CCM.0000201889.39443.D2","article-title":"Candida as a risk factor for mortality in peritonitis","volume":"34","author":"Montravers","year":"2006","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib22","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1093\/jac\/dkr394","article-title":"Antifungal use influences Candida species distribution and susceptibility in the intensive care unit","volume":"66","author":"Fournier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2026032100194839000_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"2026032100194839000_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hern\u00e1n","year":"2000","journal-title":"Epidemiology"},{"key":"2026032100194839000_bib26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jclinepi.2011.02.009","article-title":"Utility of time-dependent inverse-probability-of-treatment weights to analyze observational cohorts in the intensive care unit","volume":"64","author":"Pirracchio","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026032100194839000_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.CCM.0000251134.96055.A6","article-title":"Tracheostomy does not improve the outcome of patients requiring prolonged mechanical ventilation: a propensity analysis","volume":"35","author":"Clec\u2019h","year":"2007","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib29","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib30","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"2026032100194839000_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2013.06.005","article-title":"Candidaemia in the non-neutropenic patient: a critique of the guidelines","volume":"42","author":"Deshpande","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2026032100194839000_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026032100194839000_bib33","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"2026032100194839000_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00134-005-2571-y","article-title":"Candida spp. colonization significance in critically ill medical patients: a prospective study","volume":"31","author":"Charles","year":"2005","journal-title":"Intensive Care Med"},{"key":"2026032100194839000_bib35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"2026032100194839000_bib36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10096-014-2096-9","article-title":"Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?","volume":"33","author":"Fekkar","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026032100194839000_bib37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100194839000_bib38","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib39","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100194839000_bib40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2026032100194839000_bib41","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.3569","article-title":"Application of marginal structural models in pharmacoepidemiologic studies: a systematic review","volume":"23","author":"Yang","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026032100194839000_bib42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/1745-6215-14-399","article-title":"EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial","volume":"14","author":"Timsit","year":"2013","journal-title":"Trials"},{"key":"2026032100194839000_bib43","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JCM.00773-12","article-title":"Correlation of clinical outcomes with \u03b2-glucan levels in patients with invasive candidiasis","volume":"50","author":"Sims","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026032100194839000_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/cid\/cis456","article-title":"(1,3)-\u03b2-D-glucan as a prognostic marker of treatment response in invasive candidiasis","volume":"55","author":"Jaijakul","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032100194839000_bib45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/10\/1139\/67284935\/ajrccm_191_10_1139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/10\/1139\/67284935\/ajrccm_191_10_1139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:19:59Z","timestamp":1774066799000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/191\/10\/1139\/8504856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,5,15]]},"published-print":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201409-1701oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5]]}}}